The World Health Organization has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how ...

Current vaccines don’t provide as much protection against JN.1 and its several sub-variants that have been driving cases for ...

Talks aimed at reaching a global agreement on how to better fight pandemics will be concluded by 2025 or earlier if possible, ...

The panel endorsed targeting a variant of the coronavirus that is now receding ... By Noah Weiland and Christina Jewett A ...

The decision now goes to the full FDA. If the agency agrees with its advisory committee, the new shot will be a monovalent vaccine, offering protection against one coronavirus variant. Some previous ...

Two new COVID-19 subvariants, collectively nicknamed FLiRT ... Paxlovid is an antiviral drug that, when taken by people at risk for severe COVID-19 who have mild-to-moderate illness, reduces ...

The agency's advisory committee will vote on vaccine recommendations to target subvariants of COVID for 2024-25 respiratory ...

A standard coronavirus treatment is still unavailable, although researchers have made significant progress at developing new protocols for existing drugs and adapting them for COVID-19.

The World Health Organization said on Wednesday a death was caused by the first laboratory-confirmed human case of infection ...

But Fauci has said more testing is needed before it’s clear that the drug works against the coronavirus and is safe for COVID-19 patients. Navarro told Fox News Channel's “Fox & Friends ...

New subvariants of omicron are expected to lead to a spike in COVID-19 cases but the fallout may be less severe and the ...

A 63-year-old Saskatoon man says he has lost faith in the Saskatchewan government's health-care system, and he may move ...